The CHMP has recommended approval of Navamedic's glucosamine [Glucomed/Flexove] in the EU.

Source: Inpharma, Volume 1, Number 1557, 2006-09-30 , pp. 23-23(1)

Publisher: Adis International

Keywords: Development-status; Glucosamine, therapeutic use; Navamedic; Osteoarthritis, treatment

Document Type: Short communication

Publication date: 2006-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers